ARIC Publications
β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study." Thromb Res. 2017;155:116-120.
"Work organization and atherosclerosis: findings from the ARIC study. Atherosclerosis Risk in Communities." Am J Prev Med. 1998;14(1):9-18.
"Women's employment status and mortality: the atherosclerosis risk in communities study." J Womens Health (Larchmt). 2004;13(10):1108-18.
"Women, employment status, and hypertension: cross-sectional and prospective findings from the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 1999;9(6):374-82.
"Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease." Int J Epidemiol. 2013;42(3):849-59.
"A wide QRS/T angle in bundle branch blocks is associated with increased risk for coronary heart disease and all-cause mortality in the Atherosclerosis Risk in Communities (ARIC) Study." J Electrocardiol. 2015;48(4):672-7.
"Whole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study." Hum Mol Genet. 2017;26(17):3442-3450.
"Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program." Am J Hum Genet. 2021.
"Whole-genome sequencing association analysis of quantitative red blood cell phenotypes: The NHLBI TOPMed program." Am J Hum Genet. 2021;108(6):1165.
"Whole-Genome Sequencing Association Analyses of Stroke and Its Subtypes in Ancestrally Diverse Populations From Trans-Omics for Precision Medicine Project." Stroke. 2022;53(3):875-885.
"Whole-genome sequence-based analysis of high-density lipoprotein cholesterol." Nat Genet. 2013;45(8):899-901.
"Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program." Genome Med. 2021;13(1):136.
"Whole-exome sequencing of 14 389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors." Hum Mol Genet. 2022;31(18):3120-3132.
"Whole-Exome Sequencing in Familial Parkinson Disease." JAMA Neurol. 2016;73(1):68-75.
"Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol." Am J Hum Genet. 2014;94(2):233-45.
"Whole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis." Am J Hum Genet. 2016;99(2):481-8.
"Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease." Ann Clin Transl Neurol. 2018;5(4):406-417.
"Whole genome sequence association analysis of fasting glucose and fasting insulin levels in diverse cohorts from the NHLBI TOPMed program." Commun Biol. 2022;5(1):756.
"Whole genome sequence analysis of serum amino acid levels." Genome Biol. 2016;17(1):237.
"Whole genome sequence analysis of platelet traits in the NHLBI trans-omics for precision medicine initiative." Hum Mol Genet. 2021.
"Whole genome sequence analyses of eGFR in 23,732 people representing multiple ancestries in the NHLBI trans-omics for precision medicine (TOPMed) consortium." EBioMedicine. 2021;63:103157.
"Whole genome sequence analyses of brain imaging measures in the Framingham Study." Neurology. 2018;90(3):e188-e196.
"Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation." Mol Psychiatry. 2020;25(8):1859-1875.
"Whole Exome Sequencing in Atrial Fibrillation." PLoS Genet. 2016;12(9):e1006284.
"Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study." PLoS One. 2017;12(7):e0180046.
"Whole Blood DNA Methylation Signatures of Diet Are Associated With Cardiovascular Disease Risk Factors and All-Cause Mortality." Circ Genom Precis Med. 2020;13(4):e002766.
"White Matter Lesion Progression: Genome-Wide Search for Genetic Influences." Stroke. 2015;46(11):3048-57.
"White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2011;21(10):739-48.
"White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study." Am J Epidemiol. 2001;154(8):758-64.
"WGSA: an annotation pipeline for human genome sequencing studies." J Med Genet. 2016;53(2):111-2.
"Weight History and Subclinical Myocardial Damage." Clin Chem. 2018;64(1):201-209.
"Weight change over 9 years and subsequent risk of venous thromboembolism in the ARIC cohort." Int J Obes (Lond). 2020;44(12):2465-2471.
"Weight change among self-reported dieters and non-dieters in white and African American men and women." Eur J Epidemiol. 2001;17(10):917-23.
"Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults." Ann Epidemiol. 1997;7(4):285-93.
"Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study." Eur J Neurol. 2015;22(8):1220-7.
"Vitamin D Status and Prevalent Early Age-Related Macular Degeneration in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study." J Nutr Health Aging. 2017;21(7):772-780.
"Vitamin D and subclinical cerebrovascular disease: the Atherosclerosis Risk in Communities brain magnetic resonance imaging study." JAMA Neurol. 2014;71(7):863-71.
"Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study." Eur J Neurol. 2014;21(9):1211-8, e69-70.
"Vital exhaustion as a risk factor for adverse cardiac events (from the Atherosclerosis Risk In Communities [ARIC] study)." Am J Cardiol. 2010;105(12):1661-5.
"Vital exhaustion and sudden cardiac death in the Atherosclerosis Risk in Communities Study." Heart. 2018;104(5):423-429.
"Vital exhaustion and retinal microvascular changes in cardiovascular disease: atherosclerosis risk in communities study." Psychosom Med. 2009;71(3):308-12.
"Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study." Diabetes Care. 2005;28(6):1472-9.
"Visual Function, Physical Function, and Activities of Daily Living in Two Aging Communities." Transl Vis Sci Technol. 2021;10(14):15.
"Ventricular conduction defects and the risk of incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study." J Card Fail. 2015;21(4):307-12.
"Vasectomy, inflammation, atherosclerosis and long-term followup for cardiovascular diseases: no associations in the atherosclerosis risk in communities study." J Urol. 2002;167(1):204-7.
"Vascular risk factors and longitudinal changes on brain MRI: the ARIC study." Neurology. 2011;76(22):1879-85.
"Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study." Stroke. 2015;46(2):433-40.
"A variational Bayes discrete mixture test for rare variant association." Genet Epidemiol. 2014;38(1):21-30.
"Variation of common carotid artery elasticity with intimal-medial thickness: the ARIC Study. Atherosclerosis Risk in Communities." Ultrasound Med Biol. 1997;23(2):157-64.
"Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 2008;31(5):905-9.
"Variation in rates of fatal coronary heart disease by neighborhood socioeconomic status: the atherosclerosis risk in communities surveillance (1992-2002)." Ann Epidemiol. 2011;21(8):580-8.
"Variation in Population Attributable Fraction of Dementia Associated With Potentially Modifiable Risk Factors by Race and Ethnicity in the US." JAMA Netw Open. 2022;5(7):e2219672.
"Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease." Atherosclerosis. 2009;202(1):211-5.
"Variation in ANGPTL4 and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study." Metabolism. 2008;57(11):1591-6.
"Variation and temporal trends in the use of diagnostic testing during hospitalization for acute myocardial infarction by age, gender, race, and geography (the Atherosclerosis Risk In Communities Study)." Am J Cardiol. 2008;101(9):1219-25.
"Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study." Diabetes. 1999;48(9):1868-72.
"Variants, N-Acetylated Amino Acids, and Progression of CKD." Clin J Am Soc Nephrol. 2020;16(1):37-47.
"Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry." Nat Genet. 2009;41(8):879-81.
"Variants for HDL-C, LDL-C, and triglycerides identified from admixture mapping and fine-mapping analysis in African American families." Circ Cardiovasc Genet. 2015;8(1):106-13.
"The variable number of tandem repeat polymorphism of platelet glycoprotein Ibalpha and risk of coronary heart disease." Blood. 2004;103(3):963-5.
"Variability in ultrasonic measurements of arterial stiffness in the Atherosclerosis Risk in Communities study." Ultrasound Med Biol. 1999;25(2):175-80.
"Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study." Ultrasound Med Biol. 1996;22(5):545-54.
"The Value of Rare Genetic Variation in the Prediction of Common Obesity in European Ancestry Populations." Front Endocrinol (Lausanne). 2022;13:863893.
"Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2015;242(2):625-9.
"Validity of hospital discharge diagnosis codes for stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2014;45(11):3219-25.
"Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2012;176(8):738-43.
"Validation of the REGARDS Severe Sepsis Risk Score." J Clin Med. 2018;7(12).
"Validation of death certificate diagnosis for coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study." J Clin Epidemiol. 2001;54(1):40-50.
" "Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study." BMC Cardiovasc Disord. 2007;7:20.
"Using the whole cohort in the analysis of case-cohort data." Am J Epidemiol. 2009;169(11):1398-405.
"Using multiple measures for quantitative trait association analyses: application to estimated glomerular filtration rate." J Hum Genet. 2013;58(7):461-6.
"Using genetics to test the causal relationship of total adiposity and periodontitis: Mendelian randomization analyses in the Gene-Lifestyle Interactions and Dental Endpoints (GLIDE) Consortium." Int J Epidemiol. 2015;44(2):638-50.
"Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort)." Am J Cardiol. 2006;98(12):1609-12.
"Usefulness of Maintaining a Normal Electrocardiogram Over Time for Predicting Cardiovascular Health." Am J Cardiol. 2017;119(2):249-255.
"Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study)." Am J Cardiol. 2012;109(1):95-9.
"Usefulness of electrocardiographic QRS/T angles with versus without bundle branch blocks to predict heart failure (from the Atherosclerosis Risk in Communities Study)." Am J Cardiol. 2014;114(3):412-8.
"Use of wrapper algorithms coupled with a random forests classifier for variable selection in large-scale genomic association studies." J Comput Biol. 2009;16(12):1705-18.
"Use of troponins in the classification of myocardial infarction from electronic health records. The Atherosclerosis Risk in Communities (ARIC) Study." Int J Cardiol. 2022;348:152-156.
"Use of prescription medications with cardiovascular adverse effects among older adults in the United States." Pharmacoepidemiol Drug Saf. 2022;31(10):1027-1038.
"